Gregory K. Chow
Chief Financial OfficerMr. Gregory K. Chow, also known as Greg, CPA, MBA, BA, is Chief Financial Officer of Sutro Biopharma, Inc. from June 2, 2025. He was Chief Financial and Business Officer of NodThera Limited from August 1, 2024 to March 2025. He joined NodThera Limited on August 1, 2024. He served as Chief Financial Officer at Freenome Holdings, Inc. from January 2024 to August 2024. He had been Chief Financial Officer of Frontier Medicines Corporation since March 2021 until February 2024. He had been the Chief Financial Officer of Aptose Biosciences Inc. since December 2, 2013 until March 26, 2021 and had been its Executive Vice President since 2019 until March 26, 2021 and served as its Corporate Secretary until March 26, 2021. He was Senior Vice President of Aptose Biosciences Inc. since April 10, 2014 until 2019. He served as Chief Operating Officer at Aptose Biosciences Inc. since 2021 until March 26, 2021. Mr. Chow served as Principal Accounting Officer at Aptose Biosciences Inc. He served as the Managing Director and led the Private Placements team in the Life Sciences Investment Banking Group at Wedbush Securities from 2012 to 2013. Prior to joining Wedbush, he served as a Director in the Private Placements/Equity Capital Markets Group at RBC Capital Markets, where he led the life science private capital activities. He served as a Vice President in the Private Placement group, based in San Francisco office of RBC Capital Markets LLC since April 2006 until 2011. His transactional experience covers a broad range of equity and equity-linked financings that include Initial Public Offerings, Follow-Ons, Confidentially Marketed Public Offerings, Registered Directs, Private Investment in Public Equities (PIPEs) and private placements for private companies. From 2003 to 2006, Prior to RBC, he directed the Private Capital Group at Wells Fargo Securities (August 1998 – February 2006) and was a Senior Auditor at BDO Seidman, LLP (September 1995 – August 1998). He is a Certified Public Accountant (Inactive) in the State of California. He holds an MBA in Finance from the Wharton School at the University of Pennsylvania in 2005 and a BA in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara in 1994.
Positions
- Company NameSutro Biopharma, Inc.Stock CodeSTROPositionChief Financial OfficerColleagues
- JCJane ChungCEO & Director
- CLConnie L. MatsuiIndependent Chair of the Board
- HGHans-Peter GerberChief Scientific Officer
- JRJames R. SwartzFounder
- DLDevendra LuharSenior Vice President of Technical Operations
- JMJoseph M. LobackiIndependent Director
- JPJames P. PanekIndependent Director
- CVCarlos V. PayaChair of the Scientific Advisory Board
